Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469]
J Autoimmun. 2023 Sep 23:103116. doi: 10.1016/j.jaut.2023.103116. Online ahead of print.NO ABSTRACTPMID:37748978 | DOI:10.1016/j.jaut.2023.103116 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 25, 2023 Category: Allergy & Immunology Authors: Dongdong Zhang Andrew J Kinloch Abhinav Srinath Robert Shenkar Romuald Girard Rhonda Lightle Thomas Moore Janne Koskim äki Azam Mohsin Juli án Carrión-Penagos Sharbel Romanos Le Shen Marcus R Clark Changbin Shi Issam A Awad Source Type: research
The gut ecosystem and immune tolerance
J Autoimmun. 2023 Sep 23:103114. doi: 10.1016/j.jaut.2023.103114. Online ahead of print.ABSTRACTThe gastrointestinal tract is home to the largest microbial population in the human body. The gut microbiota plays significant roles in the development of the gut immune system and has a substantial impact on the maintenance of immune tolerance beginning in early life. These microbes interact with the immune system in a dynamic and interdependent manner. They generate immune signals by presenting a vast repertoire of antigenic determinants and microbial metabolites that influence the development, maturation and maintenance of im...
Source: Journal of Autoimmunity - September 25, 2023 Category: Allergy & Immunology Authors: Tihong Shao Ronald Hsu Desiree L Rafizadeh Li Wang Christopher L Bowlus Narendra Kumar Jayshree Mishra Suraj Timilsina William M Ridgway M Eric Gershwin Aftab A Ansari Zongwen Shuai Patrick S C Leung Source Type: research
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency
J Autoimmun. 2023 Sep 22;140:103112. doi: 10.1016/j.jaut.2023.103112. Online ahead of print.ABSTRACTTransaldolase deficiency predisposes to chronic liver disease progressing from cirrhosis to hepatocellular carcinoma (HCC). Transition from cirrhosis to hepatocarcinogenesis depends on mitochondrial oxidative stress, as controlled by cytosolic aldose metabolism through the pentose phosphate pathway (PPP). Progression to HCC is critically dependent on NADPH depletion and polyol buildup by aldose reductase (AR), while this enzyme protects from carbon trapping in the PPP and growth restriction in TAL deficiency. Although AR ina...
Source: Journal of Autoimmunity - September 24, 2023 Category: Allergy & Immunology Authors: T Winans Z Oaks G Choudhary A Patel N Huang T Faludi D Krakko J Nolan J Lewis Sarah Blair Z Lai S K Landas F Middleton J M Asara S K Chung B Wyman P Azadi K Banki A Perl Source Type: research
The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis
CONCLUSION: Polysia is more abundant in the skin and sera from patients with SSc and correlates with the degree of skin fibrosis. The aberrant expression of polySia highlights its potential use as a biomarker in patients with progressive forms of SSc. Dysregulated polySia levels in SSc further emphasizes the cancer-like phenotype present in SSc, which may promote fibrosis and immune dysregulation.PMID:37742510 | DOI:10.1016/j.jaut.2023.103110 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 24, 2023 Category: Allergy & Immunology Authors: Lamia Khan Tahlia Derksen Desiree Redmond Jan Storek Caylib Durand Robert Gniadecki Benjamin Korman Jan Willem Cohen Tervaert Ana D'Aubeterre Mohammed S Osman Lisa M Willis Source Type: research
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency
J Autoimmun. 2023 Sep 22;140:103112. doi: 10.1016/j.jaut.2023.103112. Online ahead of print.ABSTRACTTransaldolase deficiency predisposes to chronic liver disease progressing from cirrhosis to hepatocellular carcinoma (HCC). Transition from cirrhosis to hepatocarcinogenesis depends on mitochondrial oxidative stress, as controlled by cytosolic aldose metabolism through the pentose phosphate pathway (PPP). Progression to HCC is critically dependent on NADPH depletion and polyol buildup by aldose reductase (AR), while this enzyme protects from carbon trapping in the PPP and growth restriction in TAL deficiency. Although AR ina...
Source: Journal of Autoimmunity - September 24, 2023 Category: Allergy & Immunology Authors: T Winans Z Oaks G Choudhary A Patel N Huang T Faludi D Krakko J Nolan J Lewis Sarah Blair Z Lai S K Landas F Middleton J M Asara S K Chung B Wyman P Azadi K Banki A Perl Source Type: research
The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis
CONCLUSION: Polysia is more abundant in the skin and sera from patients with SSc and correlates with the degree of skin fibrosis. The aberrant expression of polySia highlights its potential use as a biomarker in patients with progressive forms of SSc. Dysregulated polySia levels in SSc further emphasizes the cancer-like phenotype present in SSc, which may promote fibrosis and immune dysregulation.PMID:37742510 | DOI:10.1016/j.jaut.2023.103110 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 24, 2023 Category: Allergy & Immunology Authors: Lamia Khan Tahlia Derksen Desiree Redmond Jan Storek Caylib Durand Robert Gniadecki Benjamin Korman Jan Willem Cohen Tervaert Ana D'Aubeterre Mohammed S Osman Lisa M Willis Source Type: research
Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues
J Autoimmun. 2023 Sep 14;140:103094. doi: 10.1016/j.jaut.2023.103094. Online ahead of print.ABSTRACTSensitization to self-peptides induces various immunological responses, from autoimmunity to tumor immunity, depending on the peptide sequence; however, the underlying mechanisms remain unclear, and thus, curative therapeutic options considering immunity balance are limited. Herein, two overlapping dominant peptides of myelin proteolipid protein, PLP136-150 and PLP139-151, which induce different forms of experimental autoimmune encephalomyelitis (EAE), monophasic and relapsing EAE, respectively, were investigated. Mice with ...
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Youwei Lin Shun Sakuraba Chandirasegaran Massilamany Jayagopala Reddy Yoshimasa Tanaka Sachiko Miyake Takashi Yamamura Source Type: research
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis
CONCLUSION: Among 25 AIH patients who were treated with immunomodulatory drugs for different reasons, the majority had a fovorable course, relapse was frequent in difficult-to-treat patients who received belimumab, and four with concomitant IBD had insufficient response.PMID:37716078 | DOI:10.1016/j.jaut.2023.103113 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Benedetta Terziroli Beretta-Piccoli Gustav Buescher George Dalekos Kalliopi Zachou Anja Geerts Nasser Semmo Mirjam Kolev Eleonora De Martin Maciej K Janik Jo ão Madaleno Milica Lalosevic Stojkovic J érôme Dumortier Thomas Vanwolleghem Ida Schregel Silj Source Type: research
Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues
J Autoimmun. 2023 Sep 14;140:103094. doi: 10.1016/j.jaut.2023.103094. Online ahead of print.ABSTRACTSensitization to self-peptides induces various immunological responses, from autoimmunity to tumor immunity, depending on the peptide sequence; however, the underlying mechanisms remain unclear, and thus, curative therapeutic options considering immunity balance are limited. Herein, two overlapping dominant peptides of myelin proteolipid protein, PLP136-150 and PLP139-151, which induce different forms of experimental autoimmune encephalomyelitis (EAE), monophasic and relapsing EAE, respectively, were investigated. Mice with ...
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Youwei Lin Shun Sakuraba Chandirasegaran Massilamany Jayagopala Reddy Yoshimasa Tanaka Sachiko Miyake Takashi Yamamura Source Type: research
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis
CONCLUSION: Among 25 AIH patients who were treated with immunomodulatory drugs for different reasons, the majority had a fovorable course, relapse was frequent in difficult-to-treat patients who received belimumab, and four with concomitant IBD had insufficient response.PMID:37716078 | DOI:10.1016/j.jaut.2023.103113 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Benedetta Terziroli Beretta-Piccoli Gustav Buescher George Dalekos Kalliopi Zachou Anja Geerts Nasser Semmo Mirjam Kolev Eleonora De Martin Maciej K Janik Jo ão Madaleno Milica Lalosevic Stojkovic J érôme Dumortier Thomas Vanwolleghem Ida Schregel Silj Source Type: research
Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues
J Autoimmun. 2023 Sep 14;140:103094. doi: 10.1016/j.jaut.2023.103094. Online ahead of print.ABSTRACTSensitization to self-peptides induces various immunological responses, from autoimmunity to tumor immunity, depending on the peptide sequence; however, the underlying mechanisms remain unclear, and thus, curative therapeutic options considering immunity balance are limited. Herein, two overlapping dominant peptides of myelin proteolipid protein, PLP136-150 and PLP139-151, which induce different forms of experimental autoimmune encephalomyelitis (EAE), monophasic and relapsing EAE, respectively, were investigated. Mice with ...
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Youwei Lin Shun Sakuraba Chandirasegaran Massilamany Jayagopala Reddy Yoshimasa Tanaka Sachiko Miyake Takashi Yamamura Source Type: research
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis
CONCLUSION: Among 25 AIH patients who were treated with immunomodulatory drugs for different reasons, the majority had a fovorable course, relapse was frequent in difficult-to-treat patients who received belimumab, and four with concomitant IBD had insufficient response.PMID:37716078 | DOI:10.1016/j.jaut.2023.103113 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Benedetta Terziroli Beretta-Piccoli Gustav Buescher George Dalekos Kalliopi Zachou Anja Geerts Nasser Semmo Mirjam Kolev Eleonora De Martin Maciej K Janik Jo ão Madaleno Milica Lalosevic Stojkovic J érôme Dumortier Thomas Vanwolleghem Ida Schregel Silj Source Type: research
Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues
J Autoimmun. 2023 Sep 14;140:103094. doi: 10.1016/j.jaut.2023.103094. Online ahead of print.ABSTRACTSensitization to self-peptides induces various immunological responses, from autoimmunity to tumor immunity, depending on the peptide sequence; however, the underlying mechanisms remain unclear, and thus, curative therapeutic options considering immunity balance are limited. Herein, two overlapping dominant peptides of myelin proteolipid protein, PLP136-150 and PLP139-151, which induce different forms of experimental autoimmune encephalomyelitis (EAE), monophasic and relapsing EAE, respectively, were investigated. Mice with ...
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Youwei Lin Shun Sakuraba Chandirasegaran Massilamany Jayagopala Reddy Yoshimasa Tanaka Sachiko Miyake Takashi Yamamura Source Type: research
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis
CONCLUSION: Among 25 AIH patients who were treated with immunomodulatory drugs for different reasons, the majority had a fovorable course, relapse was frequent in difficult-to-treat patients who received belimumab, and four with concomitant IBD had insufficient response.PMID:37716078 | DOI:10.1016/j.jaut.2023.103113 (Source: Journal of Autoimmunity)
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Benedetta Terziroli Beretta-Piccoli Gustav Buescher George Dalekos Kalliopi Zachou Anja Geerts Nasser Semmo Mirjam Kolev Eleonora De Martin Maciej K Janik Jo ão Madaleno Milica Lalosevic Stojkovic J érôme Dumortier Thomas Vanwolleghem Ida Schregel Silj Source Type: research
Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues
J Autoimmun. 2023 Sep 14;140:103094. doi: 10.1016/j.jaut.2023.103094. Online ahead of print.ABSTRACTSensitization to self-peptides induces various immunological responses, from autoimmunity to tumor immunity, depending on the peptide sequence; however, the underlying mechanisms remain unclear, and thus, curative therapeutic options considering immunity balance are limited. Herein, two overlapping dominant peptides of myelin proteolipid protein, PLP136-150 and PLP139-151, which induce different forms of experimental autoimmune encephalomyelitis (EAE), monophasic and relapsing EAE, respectively, were investigated. Mice with ...
Source: Journal of Autoimmunity - September 16, 2023 Category: Allergy & Immunology Authors: Youwei Lin Shun Sakuraba Chandirasegaran Massilamany Jayagopala Reddy Yoshimasa Tanaka Sachiko Miyake Takashi Yamamura Source Type: research
